EDGAR Filing Documents for 0001654954-20-009628

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001654954-20-009628

Filing Date

2020-08-31

Accepted

2020-08-28 17:42:24

Documents

Period of Report

2020-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDED QUARTERLY REPORT	sbfm_10qa.htm	10-Q/A	947209
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12275
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	11947
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	6975
5	IMAGE	fig1.jpg	GRAPHIC	10778
6	IMAGE	fig2.jpg	GRAPHIC	18702
7	IMAGE	fig3.jpg	GRAPHIC	18512
8	IMAGE	fig4.jpg	GRAPHIC	13525
9	IMAGE	fig5.jpg	GRAPHIC	6172
	Complete submission text file	0001654954-20-009628.txt		3073692

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	sbfm-20200630.xml	EX-101.INS	472990
11	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20200630.xsd	EX-101.SCH	20790
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20200630_cal.xml	EX-101.CAL	41814
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20200630_def.xml	EX-101.DEF	65026
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20200630_lab.xml	EX-101.LAB	153322
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20200630_pre.xml	EX-101.PRE	137852

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)